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Abstract
Nanoparticles have extremely wide applications in the medical and biological fields. They are being used in biosensors,
local drug delivery, diagnostics, and medical therapy. However, the potential effects of nanoparticles on target cell and
tissue function, apart from cytotoxicity, are not completely understood. Thus, the aim of this study was to investigate
the in vitro effects of silver nanoparticles (AgNPs) and gold nanoparticles (AuNPs) on human fibroblasts with respect to
their interaction with the extracellular matrix and in cell migration. Immunofluorescence analysis revealed that
treatment with AgNPs or AuNPs decreased collagen and laminin production at all the concentrations tested
(0.1, 1, and 10 μg/mL). Furthermore, cytofluorometric analysis showed that treatment with AgNPs reduced the
percentage of cells expressing the collagen receptor very late antigen 2, α2β1 integrin (VLA-2) and the laminin
receptor very late antigen 6, α6β1 integrin (VLA-6). In contrast, AuNP treatment increased and decreased the
percentages of VLA-2-positive and VLA-6-positive cells, respectively, as compared to the findings for the controls.
Analysis of cytoskeletal reorganization showed that treatment with both types of nanoparticles increased the formation
of stress fibres and number of cell protrusions and impaired cell polarity. Fibroblasts exposed to different
concentrations of AuNPs and AgNPs showed reduced migration through transwell chambers in the functional
chemotaxis assay. These results demonstrated that metal nanoparticles may influence fibroblast function by
negatively modulating the deposition of extracellular matrix molecules (ECM) and altering the expression of
ECM receptors, cytoskeletal reorganization, and cell migration.
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Background
Nanotechnology includes the design, characterization,
and application of structures or systems at the nano-
metre scale (size range, 1–100 nm). Applications related
to engineering, information technology, and diagnostics
are examples of consumer applications that directly im-
prove our lives. This technology is intrinsically multidis-
ciplinary and is reliant on techniques and methodologies
from many fields such as chemistry, physics, electrical
engineering, material science, and molecular biology.
Our current knowledge of the health effects of nanoma-
terials is limited and therefore this aspect deserves spe-
cial attention, particularly the potential long-term
adverse effects on living organisms [1, 2].
Metallic nanoparticles exhibit size and shape-
dependent properties that are of interest in applications
ranging from catalysts and sensing to optics, antimicro-
bial activity, and data storage [3]. Silver nanoparticles
(AgNPs) have been widely used in industrial, household,
and healthcare-related products because of their excel-
lent anti-bacterial activity, which is attributed to the
strong oxidative activity of AgNP surfaces and the re-
lease of silver ions into biological environments [4].
Similarly, the range of uses of gold nanoparticles
(AuNPs) in modern medical and biology studies is
extremely wide. In particular, it includes genomics, bio-
sensorics, local drug delivery, diagnostics, and medical
therapy. With the advances afforded by current research,
both types of nanoparticles show promise in several daily
applications [5].
In addition to the numerous advantages, it is necessary
to know the direct and indirect effects of nanoparticles
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in cells and tissues. In vitro research is the most appro-
priate tool for such analysis, for example, on NP toxicity,
as studies at the cellular level are simple and convenient
than in vivo approaches. However, cytotoxicity may not
be the only effect induced by nanoparticles. Morpho-
logical changes, cell proliferation, and migration can be
affected by nanoparticles [6].
Fibroblasts are a heterogeneous population of structural
cells that are distributed on the connective tissue with im-
portant role on the deposition of the components of the
extracellular matrix (ECM), such as types I, III, and V
collagen, and the formation of basement membranes by
secreting type IV collagen and laminin [7]. Furthermore,
fibroblasts are fundamental in maintaining homeostasis
through the secretion of growth factors, release of matrix
metalloproteinases, and involvement in wound repair
because of cytoskeletal elements that facilitate contraction
of healing wounds [8, 9].
We sought to evaluate AuNP and AgNP in vitro cyto-
toxic effects on human fibroblasts with respect to the




The human skin fibroblast cell line CCD1072Sk was
obtained from the Rio de Janeiro Cell Bank (BCRJ; Rio de
Janeiro, Brazil). Cells were cultured in RPMI 1640 growth
medium supplemented with 10% heat-inactivated foetal
bovine serum (FBS), 1% L-glutamine, and 2.5 μg/mL
gentamicin (complete medium; all purchased from Invi-
trogen, CA, USA). Cultures were maintained at 37 °C in a
humidified 5% CO2 atmosphere. Cells were passaged by
trypsin–ethylenediaminetetraacetic acid (EDTA) treat-
ment after every 3–4 days.
Nanoparticles
Both AgNPs and AuNPs were purchased from Sigma-
Aldrich (MO, USA). The AgNPs (cat. no., 730785) were
provided in a stabilized suspension in sodium citrate
solution at concentration of 0.02 mg/mL, and the
AuNPs (cat. no., 752584) were provided in a stabilized
suspension in 0.1 mM phosphate-buffered saline (PBS;
Sigma-Aldrich). The suspensions were stored at 4 °C
until use.
Cell viability assay
Cells from the CCD1072Sk line were grown in 96-well
plates with complete medium for 16 h until cellular
adhesion was attained. The cells were then treated
with AgNPs or AuNPs at concentrations of 0.1, 1, or
10 μg/mL for 24 h. After treatment, the cells were in-
cubated with 20 μL of 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (5 mg/mL; MTT;
Sigma-Aldrich) diluted in 180 μL of RPMI 1640 with
2% FBS. The MTT incubation was carried out for 4 h
in a CO2 incubator. After this period, the MTT plus
medium was completely removed and the reduction
of MTT by metabolically active cells was detected by
the solubilisation of the formed formazan crystals
with 200 μL of dimethyl sulphoxide (DMSO; Sigma-
Aldrich). Spectrophotometer readings were obtained
at an absorbance of 540 nm (TP-Reader; Thermo-
plate, Shenzhen, China).
Immunofluorescence
Fibroblasts (5 × 103) were cultured in 8-well Lab-tek
chamber glass slides (Nunc, NY, USA) with complete
medium for 16 h to allow cell adhesion. The medium
was then replaced and the cells were treated with AgNPs
or AuNPs at concentrations of 0.1, 1, or 10 μg/mL for
24 h. Non-treated cells maintained under the same con-
ditions were used as controls. After treatment, the cul-
tures were washed with PBS, fixed with 100% methanol,
and subjected to an indirect immunofluorescence assay,
as previously described [10]. Briefly, cells were re-
hydrated in PBS and incubated for 30 min with PBS
containing 1% bovine serum albumin (BSA; Sigma-
Aldrich) to block non-specific binding. Next, samples
were incubated with primary specific anti-collagen I or
anti-laminin (rabbit antibody, 1:50; Sigma-Aldrich) anti-
bodies for 1 h at humidified chamber, washed with PBS,
and incubated with goat anti-rabbit-fluorescein isothio-
cyanate (FITC)–conjugated secondary antibody (1:200,
Sigma-Aldrich) for 45 min at room temperature. Immu-
nostained samples were analysed by fluorescence mi-
croscopy (Nikon Eclipse 50i; Nikon Instruments Inc.,
CH, USA). A negative control with secondary antibody
was used. Quantitative fluorescence analysis was per-
formed by transformation of specific staining results to
pixels and by dividing the total pixel numbers by the
area analysed, thus obtaining the number of pixels/μm2,
using the ImageJ software (NIH, MD, USA).
Cytofluorometry
Cells previously exposed to AgNPs or AuNPs were incu-
bated with PBS–4% FBS containing a mixture of specific
fluorochrome-labelled antibodies used at appropriate
dilutions for 20 min at 4 °C, according to the proced-
ure specified by Ayres-Martins et al. [11]. The
reagents were as follows: anti-CD49b/PE and anti-
CD49f/PE antibodies and the isotype-matched nega-
tive controls (all from BD Pharmingen, California,
USA). After the cells were stained, they were washed,
fixed with 2% formaldehyde, and ultimately analysed
by flow cytometry on a FACS Canto II device (Becton
Dickinson, California, USA) equipped with the FACS
Diva software (Becton Dickinson). A gate excluding
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cell debris and nonviable cells was determined using
forward vs. side scatter parameters. Analyses were
performed after recording 10,000–20,000 events for
each sample.
F-actin cytoskeleton staining
The cytoskeleton structure of cultured skin fibroblasts ex-
posed or not exposed to AuNPs or AgNPs was evaluated
as previously described [12]. Fibroblasts (2 × 103) were
added in a 24-well plate with round glass coverslips previ-
ously coated or not coated with fibronectin (10 μg/mL)
and incubated for 16 h. After the cells were treated, they
were fixed and permeabilized with 4% paraformaldehyde
in PHEM solution (60 mM piperazine-1,4-bis(2-ethane-
sulfonic acid) [PIPES], 2 mM 4-(2-hydroxyethyl)pipera-
zine-1-ethanesulfonic acid [HEPES], 10 mM ethylene
glycol tetraacetic acid [EGTA], and 2 mM MgCl2; Sigma-
Aldrich) containing 0.5% Triton X-100 and 5% sucrose
(Sigma-Aldrich). Next, the cultures were stained for F-
actin by direct staining with Alexa 488-phalloidin
(Molecular Probes, OR, USA) for 1 h. After staining, the
coverslips were removed, mounted on permanent slides,
and examined using fluorescence microscopy.
Cell migration assay
Fibroblast migration assays were performed using
methods described by Leavesley et al. [13], with some
modifications, using transwell inserts with polycarbonate
membranes (diameter, 10 mm; pore size, 8.0 μm;
Corning Costar, Cambridge, USA). The selection of
the pore size was based on previous literature studies
which used this type of transwell system to evaluate
fibroblast migration [14, 15]. It was also considered
the characteristics of the fibroblast cell type, such as
their size (10–15 um). Membranes were coated with
the blocking reagent 0.1% PBS–BSA for 45 min at
37 °C in 5% CO2 humidified atmosphere. After block-
ing, cells (1 × 106) were added on the upper chamber
of the inserts and AgNPs or AuNPs were used as
chemotactic factors. Migration was permitted for 24 h
at 37 °C in a 5% CO2 incubator. After migration, the
cells at the bottom of the inserts were stained with
4′,6-diamidino-2-phenylindole (DAPI) and counted
using fluorescence microscopy.
Statistical analysis
The data obtained were analysed using one-way analysis
of variance (ANOVA) followed by Newman-Keuls post-
test. The values have been represented in terms of mean
± standard error of the mean (SEM) and were consid-
ered significant when p was ≤0.05.
Results
AuNPs and AgNPs impaired ECM deposition in fibroblasts
ECM production and deposition in several tissues are
normal functions of fibroblasts. Biological conditions
(genetic defects or diseases) that involve changes in this
functioning of fibroblasts may cause damage to homeo-
stasis of tissues or organs [16]. Our results demonstrate
that AgNPs significantly decreased laminin deposition
by fibroblasts at all the concentrations tested (0.1: 661.3
± 27.5; 1: 738.3 ± 50.7; 10: 733.9 ± 33) compared with
non-treated cells (CTR: 894.5 ± 48.3) (Fig. 1a, upper
panels and 1b). Treatment with AgNPs at 1 (2522 ±
22.9) and 10 μg/mL concentrations (2234 ± 53.9) also
decreased collagen deposition in relation to control cells
(2820 ± 44,9) (Fig. 1a, lower panels and 1c). The AuNPs,
similar to AgNPs, also decreased laminin deposition
(CTR: 939 ± 21.7; 0.1: 872.8 ± 15.1; 1: 891.0 ± 6.6; 10:
875.5 ± 8.9) and collagen deposition (CTR: 2300 ± 24.7;
0.1: 1270 ± 8; 1: 753,2 ± 6.8; 10: 736,9 ± 12.3) by fibro-
blasts after 24 h of treatment (Fig. 2a, upper panels and
2b; Fig. 2a, lower panels and 2c, respectively). When the
negative control with secondary antibody was used, it
did not show any significant immunolabelling (data not
shown).
ECM receptor expression was altered by NPs
In addition to the ECM molecules produced by fibro-
blasts, the receptors for these molecules are also
expressed on the cell membrane of the fibroblasts. In
the activated state, integrins bind to the ECM, signal to
the cytoplasm, and evoke cellular responses [17]. After
modifications of collagen and laminin deposition, we in-
vestigated the effects of NPs on the expression of the
main integrin-type receptors for these molecules, very
late antigen 2, α2β1 integrin (VLA-2) and very late anti-
gen 6, α6β1 integrin (VLA-6), by analysing their alpha
chains (CD49b and CD49f, respectively) through flow
cytometry. AgNPs caused reduction in the percentage of
cells expressing both integrin alpha chains on the fibro-
blast membrane (Table 1). Similarly, AuNPs decreased
the percentage of cells with CD49f expression (Table 1).
In contrast, treatment with 1 μg/mL of AuNPs increased
the percentage of cells expressing the CD49b chain
(Table 1).
Cytoskeletal reorganization was induced by NPs
The results described so far indicate that NPs may be
involved in ECM function. Therefore, we aimed to study
possible cytoskeleton changes under NP exposure be-
cause cytoskeleton molecules also interact with the ECM
to permit cell adhesion and migration. For this, previ-
ously NP-exposed fibroblasts were stained with F-actin-
specific Alexa 488–conjugated phalloidin. Increase of
actin fibres was observed in all AgNP-treated fibroblasts
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Fig. 1 Production of ECM molecules by fibroblasts decreased on exposure to AgNPs. The human fibroblast cell line treated with AgNPs at
concentrations of 0.1, 1, or 10 μg/mL for 24 h was analysed using indirect immunofluorescence to detect laminin and collagen-1 production.
Photomicrographs in (a) show laminin (green; upper panels) and collagen-1 (green; lower panels) production in NP-treated cells. Magnification,
200×. Graphs in b and c show the fluorescence intensity for laminin and collagen-1, respectively. Data have been presented as mean ± SEM.
CTR: non-treated cells; *p < 0.05, **p < 0.01, ***p < 0.001
Fig. 2 ECM molecule production by human fibroblasts was impaired after exposure to AuNPs. Cells treated with AuNPs at concentrations of 0.1,
1, or 10 μg/mL for 24 h were analysed using indirect immunofluorescence to detect laminin and collagen-1 production. Panels in (a) show
laminin (green staining; upper panels) and collagen-1 (green staining; lower panels) production in NP-treated cells. Magnification, 200×. Bar graphs
in b and c show fluorescence intensity for laminin and collagen-1, respectively. Data have been presented as mean ± SEM. CTR: non-treated cells;
*p < 0.05, **p < 0.01, ***p < 0.001
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when compared with control cells, accompanied with
loss of cell polarization. Fibroblasts treated with the
three studied concentrations of AuNPs exhibited an
increase in cell spreading, as compared to that noted for
non-treated cells (Fig. 3).
NPs reduced in vitro fibroblast migration
Since the NPs studied herein altered both the fibro-
blast ECM and cytoskeleton, we hypothesized that ex-
posure to this material would affect fibroblast
motility. Therefore, we evaluated the migration of
these cells on transwell inserts. Both AuNP and
AgNP treatments were found to reduce the number
of migrating cells. The reduction was observed on
fibroblasts treated with 1 (143.0 ± 3.1) and 10 μg/mL
(140.3 ± 2.5) of AgNPs compared with non-treated
fibroblasts (154.5 ± 2.3) (Fig 4a, left graph and 4b,
upper panels). All concentrations of AuNPs reduced
fibroblast migration (CTR: 157.0 ± 3.3; 0.1: 100.8 ± 4.3;
1: 123.5 ± 2; 10: 143.8 ± 2.2), but the decrease was
more pronounced for the 0.1 μg/mL concentration of
AuNPs (Fig. 4a, right graph and 4b, lower panels).
NPs did not alter cell viability
The MTT assay was performed to verify if the impair-
ment of function induced by NPs in fibroblasts could be
due to interference with cell viability. Both AuNP and
AgNP treatments did not alter fibroblast viability (Fig.5;
Additional file 1). This result indicates that AuNPs and
AgNPs may influence important aspects of in vitro fibro-
blast function and that this impairment does not involve
cellular alterations related to metabolism and cell
viability.
Discussion
The development of nanoparticles for biomedical appli-
cations, including medical imaging and drug delivery, is
currently undergoing dramatic expansion. However, as
the range of nanoparticle types and applications in-
creases, it is also clear that the potential toxicities of
these novel materials and the properties driving such
toxic responses must also be understood [18]. Thus,
unfavourable tissue reactions promoted by NPs, such as
degeneration, necrosis, inflammation, tissue fibrosis, or
even the induction of tumour growth, have been the tar-
get of monitoring [19–22]. In the current study, AgNPs
and AuNPs promoted toxicological effects on fibroblasts,
as shown by decreased ECM deposition, imbalanced ex-
pression of integrins, impaired F-actin cytoskeletal
reorganization, and decreased human fibroblast migra-
tion, without affecting cell viability.
Human dermal fibroblast cells are found throughout
the human body and are responsible for the mainten-
ance of soft tissue integrity through their primary func-
tion, which is collagen expression. Collagen is the most
abundant protein in the ECM [23] and provides binding
sites for adhesion molecules involved in cell attachment
Table 1 Percentage of cells expressing VLA-2 and VLA-6 on
their surface on NP exposure
Groups VLA-2 (CD49b) VLA-6 (CD49f)
AgNPs
CTR 66.03 ± 1.50 22.78 ± 0.84
0.1 μg/mL 54.28 ± 1.14** 20.31 ± 0.42*
1 μg/mL 58.57 ± 1.54* 19.99 ± 0.45*
10 μg/mL 47.69 ± 0.51*** 19.82 ± 0.33*
AuNPs
CTR 64.35 ± 1.28 19.56 ± 0.43
0.1 μg/mL 79.17 ± 5.67 17.92 ± 0.37*
1 μg/mL 80.39 ± 0.98*** 17.55 ± 0.25*
10 μg/mL 61.67 ± 1.38 17.31 ± 0.26**
CTR: non-treated cells; *p < 0.05; **p < 0.01; *** p < 0.001
Fig. 3 Cytoskeletal reorganization in human fibroblasts treated with NPs. Cells exposed to AuNPs and AgNPs at 0.1, 1, or 10 μg/mL for 24 h were
stained with phalloidin to analyse F-actin distribution (green staining). Photomicrographs revealed alterations in cell polarity and stress fibres in
NP-treated cells. CTR: non-treated cells. Magnification, 200×
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[24–26], such as those for direct association between
collagen IV and laminin [27]. In the current study, it was
found that collagen and laminin deposition on fibro-
blasts was decreased by treatments with all concentra-
tions of AgNPs and AuNPs, except for 0.1 μg/mL AgNP,
which did not alter collagen deposition. This result is in
agreement with similar study in that human fibroblast
cells showed 20 and 95% reduction of collagen pro-
duction following exposure to AuNPs and AgNPs, re-
spectively [28]. Other studies have shown that protein
synthesis for ECM formation is altered dramatically
and that significantly lesser collagen and fibronectin
are expressed by cells exposed to AuNPs [6, 29]. In
previous studies, treatment with titanium dioxide NP
(TiO2) also decreased the ability of human fibroblasts
to cause collagen contraction [30] and to induce
procollagen-1 repression [31].
To better understand the basis of decrease in ECM
proteins, integrins, which are cell surface proteins that
bind to ECM molecules to mediate cell–cell adhesion
[32], were evaluated. Collagen and laminin integrin re-
ceptor expression was determined by evaluating VLA-2
integrin alpha chain (α2; CD49b) and VLA-6 integrin
alpha chain (α6; CD49f) because the main receptors for
Fig. 4 NPs reduced human fibroblast migration in vitro. AgNPs and AuNPs were used as chemotactic factors for fibroblasts in transwell migration
assays. Cells were permitted to migrate for 24 h at 37 °C in a 5% CO2 incubator. Fibroblasts allowed to migrate through medium alone were used
as controls (CTR). After migration, the cells at the bottom of the inserts were stained with DAPI and counted using fluorescence microscopy. Bar
graphs in a show the mean ± SEM values for the number of migrating cells. *p < 0.05, **p < 0.01, ***p < 0.001. Representative photomicrographs
of the DAPI-stained nucleus (blue staining) used for quantification of migrating cells are shown in b. Magnification, 200×
Fig. 5 NP exposure did not alter fibroblast viability. After the human fibroblasts were treated with AgNPs and AuNPs, they were analysed using
the MTT assay to measure cell viability as described in the Methods section. Cells treated with Tween were used as the positive control for cell
death and cells cultured with medium alone were used as controls (CTR). The graphs show the cell viability percentage for AgNP-treated cells
(a) and AuNP-treated cells (b) and their respective controls. Data are presented as mean ± SEM
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the different collagen types are α1β1 (VLA-1) and α2β1
(VLA-2) integrins [33, 34] and the receptor involved in
the adhesion of several cell types to laminin is the α6β1
(VLA-6) integrin [35, 36]. In our current study, we
found that incubation with AgNPs markedly decreased
the percentage of cells expressing the α2 chain and the
α6 chain, representing the VLA-2 and VLA-6 integrins,
respectively. A similar decrease was also observed on
VLA-6-expressing cells after AuNP exposure. Use of
1 μg/mL AuNPs increased the percentage of VLA-2-
expressing fibroblasts, whereas AuNP treatment at 0.1
and 10 μg/mL concentrations did not affect the expres-
sion of this receptor. Currently, the reasons for the
increase in VLA-2-expressing cells after AuNP incubation
are unclear. A possible explanation is that the increase or
decrease in integrin expression may not directly affect cell
function but may affect the activation state of the recep-
tors, as seen in the study by Smaniotto et al. [10]. In that
study, thymocytes from growth hormone-transgenic mice
showed increased adhesion and migration through lam-
inin substrate, but VLA-6 expression did not change sig-
nificantly, indicating an increase in the activation levels of
this integrin without increase in the expression of the cor-
responding protein. Therefore, it is necessary to perform
more studies on intracellular signalling to understand the
mechanisms underlying the effects of AuNPs on VLA-2
expression on fibroblasts.
Disruption of the expression of ECM proteins may
responsible for the lack of tension in the actin fibres
because these fibres would be anchored to integrins.
Integrins bound to Arg-Gly-Asp (RGD) domains found
on secreted ECM proteins, which are primarily collagen
and fibronectin in the case of fibroblasts [29]. When the
F-actin cytoskeleton was analysed, imbalanced effects
were found for fibroblasts treated with AgNPs and
AuNPs. Cells treated with AgNPs showed a non-
polarized shape, in contrast to that noted in tissue cul-
ture, in that many cells can adopt a polarized morph-
ology that allows them to move through the polarized
and dynamic reorganized actin cytoskeleton [37]. Add-
itionally, stress fibre formation, pivotal to maintaining
the polarized cell structure [38, 39], also increased after
AgNP treatments. This impairment was similar to that
observed in fibroblast mutants that lacked the glycopro-
tein transmembrane SHPS-1 and exhibited increased
formation of actin stress fibres and focal adhesions but
were defective in subsequent polarized extension [40].
Previous studies also demonstrated the impact of NP ex-
posure on fibroblast cytoskeleton, such as the filament
disruption and actin stress fibre disappearance promoted
by AuNPs [6, 31], and induced repression of α-actin
expression by TiO2 NPs [29]. In our study, AuNPs
exposure led to increase in cell spreading, without
significant changes in cell shape and polarization.
In directed cell migration, spatial asymmetry necessary
for early events that establish polarized leading and trail-
ing edges is acquired [41]. Cell migration was performed
under chemotactic effects of AgNPs and AuNPs, but this
process was completely impaired by nanoparticle treat-
ments because the fibroblast migration capacity was dra-
matically reduced by AgNPs at concentrations of 1 and
10 μg/mL and by AuNPs at all concentrations. Similarly,
TiO2NP also decreased fibroblast mobility and impaired
cell function, with the latter effect being more potent in
leading to damage [30]. A possible mechanism for re-
duction of migration is the increased formation of intra-
cellular stress fibres, which is correlated with enhanced
cell adhesion; mammary migrating cells have fewer
stress fibres [39, 42]. Furthermore, studies have shown
that decrease in cellular motility is also induced by
AuNPs because of abnormal formation of actin filaments
on dermal fibroblasts [6, 43]. Although fibroblast migra-
tion has been shown to involve α2β1 integrin [44, 45],
the increase in VLA-2 expression due to exposure to
1 μg/mL AuNPs could not prevent reduction of migra-
tion. This is consistent with emerging evidence showing
that increase or decrease in integrin expression may not
directly affect migration, as shown by Nagib et al. [46].
In that study, thymocytes from diabetic mice that
expressed lower VLA-5 and VLA-6 levels did not show
altered migration ability in vitro, indicating that only
lower integrin expression on the cell surface is not suffi-
cient to hinder migration.
Despite the cytotoxic effects of AgNPs and AuNPs
with respect to fibroblast function, these cells were not
sensitive to the tested concentrations of both AgNPs
and AuNPs in the MTT assay. These results are consist-
ent with previous study performed with PC-3 and MCF-
7 cells, which reported that AuNPs coated with citrate,
starch, and Arabic gum, and studied using different cyto-
toxicity assays (e.g., MTT assay, neutral red, and lactate
dehydrogenase release) showed excellent cell viability,
indicating that AuNPs were nontoxic to the array of cells
tested [43] (Additional File 1). Also, it was shown that
AuNPs can alter cell function without modifications on
cell viability, corroborating with our findings. It was ob-
served that macrophages from RAW 264 cell lines ex-
posed to 100–400 μg/ml of AuNPs stabilized with
polyvinylpyrrolidone (PVP), with approximately 36 nm
of diameter and spherical shape inhibited metallopro-
teinase (MMP) activity, while they did not alter cell cyto-
toxicity [47]. The same group showed that these AuNPs
did not alter fibroblast viability, while they could inhibit
MMP-1 activity [48]. It is possible that the effect on cell
viability may be related with NP size, since human
dermal fibroblasts treated with 30, 50, and 90 nm
AuNPs have a decrease on cell viability in a dose-
dependent manner, with a reduction in cell survival at
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concentrations up to 5 μg/ml [49]. In this case, the re-
duction was observed after 48 h. In contrast, the AgNPs
induced marked adverse effects on cell viability and
could induce changes in cell shape, decrease cell viabil-
ity, increase lactate dehydrogenase release, and finally
cause cell apoptosis and necrosis [3, 6, 50, 51].
Conclusions
Our findings demonstrate that both AgNPs and AuNPs
can impair fibroblast function and cause decreased ECM
deposition, imbalanced integrin expression, impaired F-
actin cytoskeletal reorganization, and decreased cell
migration, without loss of cell viability. These results
highlight the importance of performing biocompatibility
studies using different approaches besides from cell via-
bility to better understand the effects of NPs on their
target structures before they can be safely applied in
clinical trials.
Additional file
Additional file 1: Figure S1. Effects of NP exposure on fibroblast
viability. After the human fibroblasts were treated with AgNPs and
AuNPs, they were analysed using the MTT assay to measure cell viability.
Cells treated with Tween were used as the positive control for cell death
and cells cultured with medium alone were used as negative controls
(CTR). The graphs show the cell viability percentage for AgNP-treated
cells (a) and AuNP-treated cells (b) and their respective controls. Data are
presented as mean ± SEM. (DOCX 47 kb)
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